Caribou Biosciences
CRBU
CRBU
126 hedge funds and large institutions have $238M invested in Caribou Biosciences in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 33 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
12% less call options, than puts
Call options by funds: $99K | Put options by funds: $112K
13% less capital invested
Capital invested by funds: $273M → $238M (-$34.8M)
32% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 19
Holders
126
Holding in Top 10
3
Calls
$99K
Puts
$112K
Top Buyers
| 1 | +$4.19M | |
| 2 | +$2.93M | |
| 3 | +$1.3M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.06M |
| 5 |
State Street
Boston,
Massachusetts
|
+$830K |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$1.01M | |
| 3 | -$766K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$709K |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$658K |